🕵️ Onkure Therapeutics, Inc. ($OKUR)
SEC insider & ownership activity, last 12 months · CIK 1637715 · every row links its SEC filing
Over the last 12 months insiders sold $5K with no open-market buying against it. Jason A. Leverone sold $4K (Sep–Jun). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $5K (8 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Jason A. Leverone | 0 | – | 4 | $4K | Jun 22, 2026 |
| Nicholas A. Saccomano | 0 | – | 4 | $1K | Jun 22, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Access Industries Holdings LLC | 20.0% | 13D | Mar 31, 2026 | filing ↗ | |
| Access Industries Management, LLC | 20.0% | 13D | Mar 31, 2026 | filing ↗ | |
| Len Blavatnik | 20.0% | 13D | Mar 31, 2026 | filing ↗ | |
| AI Biotechnology LLC | 20.0% | 13D | Mar 31, 2026 | filing ↗ | |
| Acorn Bioventures, L.P. | 13.3% | 13D | May 15, 2025 | filing ↗ | |
| Acorn Capital Advisors GP, LLC | 13.3% | 13D | May 15, 2025 | filing ↗ | |
| RA Capital Management, L.P. | 9.9% | 13G | Apr 7, 2026 | filing ↗ | |
| Peter Kolchinsky | 9.9% | 13G | Apr 7, 2026 | filing ↗ | |
| Rajeev Shah | 9.9% | 13G | Apr 7, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 9.9% | 13G | Apr 7, 2026 | filing ↗ | |
| Anders Hove | 9.5% | 13G | Apr 1, 2026 | filing ↗ | |
| Acorn Bioventures 2, L.P. | 8.8% | 13D | May 15, 2025 | filing ↗ | |
| Stepstone Group LP | 6.6% | 13G | Apr 7, 2026 | filing ↗ | |
| Stepstone Master G, L.P. | 6.6% | 13G | Apr 7, 2026 | filing ↗ | |
| Stepstone VC MI-G GP, LLC | 6.6% | 13G | Apr 7, 2026 | filing ↗ | |
| SHAY Capital LLC | 6.3% | 13G | May 29, 2025 | filing ↗ | |
| SHAY Capital Holdings LLC | 6.3% | 13G | May 29, 2025 | filing ↗ | |
| Trails EDGE Capital Partners, LP | 6.0% | 13G | Apr 7, 2026 | filing ↗ | |
| Trails EDGE Biotechnology Master Fund, LP | 6.0% | 13G | Apr 7, 2026 | filing ↗ | |
| Ortav Yehudai | 6.0% | 13G | Apr 7, 2026 | filing ↗ | |
| ADAR1 Capital Management, LLC | 6.0% | 13G | May 15, 2026 | filing ↗ | |
| Daniel Schneeberger | 6.0% | 13G | May 15, 2026 | filing ↗ | |
| Prosight Management, LP | 5.8% | 13G | Nov 28, 2025 | filing ↗ | |
| Prosight Partners, LLC | 5.8% | 13G | Nov 28, 2025 | filing ↗ | |
| W. Lawrence Hawkins | 5.8% | 13G | Nov 28, 2025 | filing ↗ | |
| BVF Partners L P/IL | 5.3% | 13G | May 27, 2026 | filing ↗ | |
| BVF INC/IL | 5.3% | 13G | May 27, 2026 | filing ↗ | |
| Mark N. Lampert | 5.3% | 13G | May 27, 2026 | filing ↗ | |
| Cantor Fitzgerald Securities | 5.2% | 13G | Aug 14, 2025 | filing ↗ | |
| Cantor Fitzgerald & Co. | 5.2% | 13G | Aug 14, 2025 | filing ↗ | |
| Cantor Fitzgerald, L.P. | 5.2% | 13G | Aug 14, 2025 | filing ↗ | |
| CF Group Management, Inc. | 5.2% | 13G | Aug 14, 2025 | filing ↗ | |
| Acorn Bioventures 2, L.P. | 5.0% | 13G | Apr 1, 2026 | filing ↗ | |
| Acorn Capital Advisors GP 2, LLC | 5.0% | 13G | Apr 1, 2026 | filing ↗ | |
| ADAR1 Capital Management GP, LLC | 5.0% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 3, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Earnings (2.02) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 27, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 27, 2026 | filing ↗ |
| Other events (8.01) | Mar 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 27, 2026 | filing ↗ |
| Earnings (2.02) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Material agreement (1.01) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Earnings (2.02) | Aug 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2025 | filing ↗ |